These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1361741)

  • 1. Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate.
    Aziz TZ; Peggs D; Agarwal E; Sambrook MA; Crossman AR
    Br J Neurosurg; 1992; 6(6):575-82. PubMed ID: 1361741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate.
    Aziz TZ; Peggs D; Sambrook MA; Crossman AR
    Mov Disord; 1991; 6(4):288-92. PubMed ID: 1758446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Mitchell IJ; Clarke CE; Boyce S; Robertson RG; Peggs D; Sambrook MA; Crossman AR
    Neuroscience; 1989; 32(1):213-26. PubMed ID: 2586750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does increased excitatory drive from the subthalamic nucleus contribute to dopaminergic neuronal death in Parkinson's disease?
    Luquin MR; Saldise L; Guillén J; Belzunegui S; San Sebastián W; Izal A; Garrido P; Vázquez M
    Exp Neurol; 2006 Oct; 201(2):407-15. PubMed ID: 16806173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus.
    Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
    Neurosci Lett; 1985 Oct; 61(1-2):195-200. PubMed ID: 3878482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.
    Schneider JS; Yuwiler A; Markham CH
    Brain Res; 1987 May; 411(1):144-50. PubMed ID: 2886180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.
    Burns RS; Markey SP; Phillips JM; Chiueh CC
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):166-8. PubMed ID: 6608980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum.
    Herrero MT; Hirsch EC; Javoy-Agid F; Obeso JA; Agid Y
    Brain Res; 1993 Oct; 624(1-2):281-5. PubMed ID: 7902770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a tyrosine hydroxylase immunocytochemical study in monkey.
    Kitt CA; Cork LC; Eidelberg F; Joh TH; Price DL
    Neuroscience; 1986 Apr; 17(4):1089-103. PubMed ID: 2872615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease.
    Schwartzman RJ; Alexander GM
    Brain Res; 1985 Dec; 358(1-2):137-43. PubMed ID: 3878182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subthalamotomy improves MPTP-induced parkinsonism in monkeys.
    Guridi J; Herrero MT; Luquin R; Guillen J; Obeso JA
    Stereotact Funct Neurosurg; 1994; 62(1-4):98-102. PubMed ID: 7631095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in multiple tyrosine hydroxylase mRNAs in the substantia nigra, locus coeruleus and adrenal gland of MPTP-treated parkinsonian monkeys.
    Ohye T; Ichinose H; Ogawa M; Yoshida M; Nagatsu T
    Neurodegeneration; 1995 Mar; 4(1):81-5. PubMed ID: 7600187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immuno-histochemical study of ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys.
    Goto K; Mochizuki H; Imai H; Akiyama H; Mizuno Y
    Brain Res; 1996 Jun; 724(1):125-8. PubMed ID: 8816266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake.
    Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
    Neurosci Lett; 1986 Jan; 63(1):61-5. PubMed ID: 3485267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates.
    Zuddas A; Oberto G; Vaglini F; Fascetti F; Fornai F; Corsini GU
    J Neurochem; 1992 Aug; 59(2):733-9. PubMed ID: 1629743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates.
    Albanese A; Granata R; Gregori B; Piccardi MP; Colosimo C; Tonali P
    Neuroscience; 1993 Aug; 55(3):823-32. PubMed ID: 8105418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotoxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the cat. Tyrosine hydroxylase immunohistochemistry.
    Schneider JS; Markham CH
    Brain Res; 1986 May; 373(1-2):258-67. PubMed ID: 2872936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on ultrastructure of nigral neuromelanin in Macaca fascicularis.
    Levi AC; DeMattei M; Ravazzani R; Corvetti G; Golden GT; Fariello RG
    Neurosci Lett; 1989 Jan; 96(3):271-6. PubMed ID: 2785665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.
    Chiueh CC; Burns RS; Markey SP; Jacobowitz DM; Kopin IJ
    Life Sci; 1985 Jan; 36(3):213-8. PubMed ID: 3871241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism.
    Bergman H; Wichmann T; Karmon B; DeLong MR
    J Neurophysiol; 1994 Aug; 72(2):507-20. PubMed ID: 7983515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.